Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Mitigate Risk and Increase Success of Lupus Clinical Trials

Andrea Peirce, Peter Lipsky, MD, and Benjamin D. Schwartz, MD, PhD  |  August 1, 2010

Design strategies from a Lupus Research Institute conference

A Look Back & A Look Ahead: ACR Research and Education Foundation Turns 25

Heather Haley, MS  |  August 1, 2010

The ACR Research and Education Foundation turns 25

What is ICD-9 Coding?

From the College  |  August 1, 2010

The International Classification of Diseases Clinical Modification, 9th Revision (ICD-9 CM) is a list of codes intended for the classification of diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease. The numerical format of the diagnosis codes usually ranges from three to five digits that are assigned to a unique category.

Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction

From the College  |  August 1, 2010

A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).

Support for Friends of Rheumatology

From the College  |  August 1, 2010

RheumPAC—the voluntary, nonpartisan political action committee of the ACR—works to support and elect pro-rheumatology candidates. RheumPAC representatives were busy in May meeting with supporters of the rheumatology community.

Advocates for Arthritis: My First Time on the Hill

Annelle B. Reed, MSN, CPNP  |  August 1, 2010

When I first read the request for advocates to fly in to Washington D.C., I was intrigued and curious. I’ve heard of visits to Capitol Hill to present important medical issues but was not really sure how the process worked. Politics can seem daunting and complicated, but I know it is necessary to get Congress on board to address medical care. I was excited to be accepted and ready to learn how to best help my patients in the political arena.

What Does Meaningful Use Really Mean?

From the College  |  August 1, 2010

On July 13, the Centers for Medicare and Medicaid Services (CMS) announced the publication of the final rule for the electronic health record (EHR) incentive program. The final rule announcement ended the holding pattern for providers eager to make the switch from paper to digital medical records.

Our Commitment to Research

Stanley B. Cohen, MD  |  August 1, 2010

The ACR has a wide range of programs to support investigations in rheumatology

REF Investigators’ Meeting Brings Researchers Together to Search for RA Cure

Charlotte Huff  |  August 1, 2010

REF Investigators’ Meeting brings researchers together to search for RA cure

Aggressive Urate Lowering Needed for Gout

Kathy Holliman  |  July 1, 2010

Patients with gout at increased risk for cardiovascular disease and adverse event

  • « Previous Page
  • 1
  • …
  • 277
  • 278
  • 279
  • 280
  • 281
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences